Context Capital Management’s Cardio Diagnostics Holdings Inc Warrant CDIOW Stock Holding History

Context Capital Management’s Portfolio CDIOW Stock Details CDIOW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.22K	Hold	81,500	–	–	﹤0.01%	420
2026 Q1	$1.34K	Hold	81,500	–	–	﹤0.01%	386
2025 Q4	$2.11K	Hold	81,500	–	–	﹤0.01%	319
2025 Q3	$1.66K	Hold	81,500	–	–	﹤0.01%	264
2025 Q2	$1.32K	Hold	81,500	–	–	﹤0.01%	246
2025 Q1	$3.26K	Hold	81,500	–	–	﹤0.01%	194
2024 Q4	$6.76K	Hold	81,500	–	–	﹤0.01%	192
2024 Q3	$3.17K	Hold	81,500	–	–	﹤0.01%	256
2024 Q2	$3.17K	Hold	81,500	–	–	﹤0.01%	207
2024 Q1	$8.67K	Hold	81,500	–	–	﹤0.01%	201
2023 Q4	$14.2K	Hold	81,500	–	–	﹤0.01%	169
2023 Q3	$3K	Hold	81,500	–	–	﹤0.01%	263
2023 Q2	$15K	Hold	81,500	–	–	﹤0.01%	183
2023 Q1	$26K	Sell	81,500 -40,000	-33%	-$9.39K	﹤0.01%	203
2022 Q4	$6K	Hold	121,500	–	–	﹤0.01%	349
2022 Q3	$23K	Hold	121,500	–	–	﹤0.01%	411
2022 Q2	$19K	Sell	121,500 -3,500	-3%	-$681	﹤0.01%	471
2022 Q1	$25K	Buy	+125,000	New	+$29.7K	﹤0.01%	559

Other funds holding CDIOW

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

SCM

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Context Capital Management's CDIOW Position: Q2 2026 in Review

Context Capital Management held its Cardio Diagnostics Holdings Inc Warrant (CDIOW) position steady in Q2 2026 at 81,500 shares worth $1.22K. The position accounts for ﹤0.01% of the portfolio, ranked #420.

Context Capital Management first reported a position in CDIOW in Q1 2022 and has held it in 18 quarters since. The position peaked at $26K in Q1 2023. 7 funds tracked by Wall St. Rank hold CDIOW as of Q2 2026.

Context Capital Management held 81,500 shares of Cardio Diagnostics Holdings Inc Warrant worth $1.22K as of Q2 2026.
Context Capital Management left its Cardio Diagnostics Holdings Inc Warrant share count unchanged in Q2 2026.
Cardio Diagnostics Holdings Inc Warrant made up ﹤0.01% of Context Capital Management's portfolio in Q2 2026, its #420 holding.
Context Capital Management first reported a position in Cardio Diagnostics Holdings Inc Warrant in Q1 2022 and has held it in 18 quarters since.
Context Capital Management's Cardio Diagnostics Holdings Inc Warrant position peaked at $26K in Q1 2023.
7 funds tracked by Wall St. Rank held Cardio Diagnostics Holdings Inc Warrant as of Q2 2026.

Based on Context Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.